Stage IIIB (locally advanced) or Stage IV (metastatic) non-small cell lung cancer (NSCLC)

Treatment Phase: Continuing treatment

Clinical criteria:

  • The treatment must be as monotherapy,

AND

  • Patient must have previously received PBS-subsidised treatment with this drug for this condition,

AND

  • Patient must not develop disease progression while receiving PBS-subsidised treatment with this drug for this condition.

Treatment criteria:

  • Must be treated by a medical practitioner; OR

  • Must be treated by a nurse practitioner where both of the following are occurring: (i) patient care is being shared with a medical practitioner, (ii) the prescription continues existing therapy with this medicine.

Note

No increase in the maximum quantity or number of units may be authorised.

Note

No increase in the maximum number of repeats may be authorised.

Note

Special Pricing Arrangements apply.